Samil Pharmaceutical Co.,Ltd (KRX:000520)
South Korea
· Delayed Price · Currency is KRW 9,100.00
-290.00 (-3.09%)
Apr 29, 2026, 3:30 PM KST
KRX:000520 Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | -34,664 | -5,629 | 1,664 | -28.29 | -5,347 | Upgrade
|
| Depreciation & Amortization | 9,197 | 7,263 | 5,368 | 4,989 | 4,712 | Upgrade
|
| Loss (Gain) From Sale of Assets | -1.14 | 30.28 | -1,893 | -463.24 | -365.84 | Upgrade
|
| Asset Writedown & Restructuring Costs | 1,685 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 229.35 | - | 585 | 7.11 | - | Upgrade
|
| Loss (Gain) on Equity Investments | -0.53 | -0.42 | -0.49 | -0.37 | - | Upgrade
|
| Provision & Write-off of Bad Debts | 1,073 | 1,492 | -1,187 | 773.39 | 476.66 | Upgrade
|
| Other Operating Activities | 16,045 | 7,486 | 7,976 | 8,526 | 7,130 | Upgrade
|
| Change in Accounts Receivable | 2,322 | -2,112 | -446.53 | -3,783 | -1,151 | Upgrade
|
| Change in Inventory | -887.69 | -3,133 | -7,914 | -644.11 | -181.39 | Upgrade
|
| Change in Accounts Payable | 89.47 | -2,014 | 7,295 | 5,131 | -2,278 | Upgrade
|
| Change in Other Net Operating Assets | 5,481 | -791.29 | 298.63 | -10,354 | -1,578 | Upgrade
|
| Operating Cash Flow | 568.16 | 2,590 | 11,746 | 4,154 | 1,417 | Upgrade
|
| Operating Cash Flow Growth | -78.06% | -77.95% | 182.76% | 193.18% | -81.78% | Upgrade
|
| Capital Expenditures | -7,457 | -5,372 | -24,244 | -48,481 | -32,828 | Upgrade
|
| Sale of Property, Plant & Equipment | 4.54 | 39.36 | 5,213 | 272.79 | 538.32 | Upgrade
|
| Sale (Purchase) of Intangibles | -66.29 | -240.55 | -91.65 | -175.67 | 217.13 | Upgrade
|
| Investment in Securities | -299.98 | -750 | -585 | 11,262 | -9,800 | Upgrade
|
| Other Investing Activities | -150.32 | -38.78 | -69.61 | 1,186 | -3,436 | Upgrade
|
| Investing Cash Flow | -7,969 | -6,361 | -19,778 | -35,936 | -45,308 | Upgrade
|
| Short-Term Debt Issued | 22,523 | 22,499 | 7,005 | 377.14 | 6,613 | Upgrade
|
| Long-Term Debt Issued | 16,548 | 52,599 | 31,908 | 77,479 | 34,997 | Upgrade
|
| Total Debt Issued | 39,071 | 75,098 | 38,913 | 77,856 | 41,609 | Upgrade
|
| Short-Term Debt Repaid | -18,888 | -58,771 | -8,612 | -30,993 | -2,980 | Upgrade
|
| Long-Term Debt Repaid | -4,896 | -850.33 | -14,214 | -14,279 | -1,431 | Upgrade
|
| Total Debt Repaid | -23,783 | -59,622 | -22,827 | -45,272 | -4,412 | Upgrade
|
| Net Debt Issued (Repaid) | 15,288 | 15,476 | 16,086 | 32,584 | 37,198 | Upgrade
|
| Repurchase of Common Stock | - | - | - | - | -2,492 | Upgrade
|
| Dividends Paid | - | - | - | -1,001 | -938.64 | Upgrade
|
| Other Financing Activities | -6,638 | -7,494 | -7,603 | -1,877 | -1,893 | Upgrade
|
| Financing Cash Flow | 8,650 | 7,982 | 8,483 | 29,706 | 31,874 | Upgrade
|
| Foreign Exchange Rate Adjustments | 25.56 | 20.14 | -1,448 | -12.81 | 11.66 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | -0 | 0 | - | - | - | Upgrade
|
| Net Cash Flow | 1,275 | 4,231 | -997.32 | -2,089 | -12,005 | Upgrade
|
| Free Cash Flow | -6,888 | -2,782 | -12,498 | -44,327 | -31,411 | Upgrade
|
| Free Cash Flow Margin | -3.28% | -1.27% | -6.37% | -24.67% | -23.40% | Upgrade
|
| Free Cash Flow Per Share | -324.47 | -154.68 | -864.01 | -3179.28 | -2271.39 | Upgrade
|
| Cash Interest Paid | 6,638 | 7,444 | 7,573 | 1,877 | 1,893 | Upgrade
|
| Cash Income Tax Paid | 2,088 | 3,547 | 1,832 | -36.65 | 2,438 | Upgrade
|
| Levered Free Cash Flow | -6,759 | -8,442 | -27,525 | -37,685 | -33,164 | Upgrade
|
| Unlevered Free Cash Flow | -1,277 | -5,281 | -25,310 | -35,020 | -29,287 | Upgrade
|
| Change in Working Capital | 7,004 | -8,051 | -766.85 | -9,650 | -5,189 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.